Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 Jan 10.
Published in final edited form as: J Am Chem Soc. 2013 Aug 1;135(32):12013–12022. doi: 10.1021/ja405318d

In Vitro and Cellular Self-Assembly of a Zn-Binding Protein Cryptand via Templated Disulfide Bonds

Annette Medina-Morales 1, Alfredo Perez 1, Jeffrey D Brodin 1, F Akif Tezcan 1,*
PMCID: PMC4289141  NIHMSID: NIHMS643742  PMID: 23905754

Abstract

Simultaneously strong and reversible through redox chemistry, disulfide bonds play a unique and often irreplaceable role in the formation of biological and synthetic assemblies. In an approach inspired by supramolecular chemistry, we report here that engineered noncovalent interactions on the surface of a monomeric protein can template its assembly into a unique cryptand-like protein complex (C81/C96RIDC14) by guiding the selective formation of multiple disulfide bonds across different interfaces. Owing to its highly interconnected framework, C81/C96RIDC14 is well preorganized for metal coordination in its interior, can support a large internal cavity surrounding the metal sites, and can withstand significant alterations in inner-sphere metal coordination. C81/C96RIDC14 self-assembles with high fidelity and yield in the periplasmic space of E. coli cells, where it can successfully compete for Zn(II) binding.

graphic file with name nihms643742u1.jpg

INTRODUCTION

Chemical templating, generally defined as the use of non-covalent interactions to spatially organize molecules to promote the selective formation of covalent bonds between them,1,2 is pervasive in nature. While the polymerization of DNA is the first example that comes to mind, essentially all enzyme-catalyzed bond-forming reactions can be considered as being templated by the noncovalent framework of enzymes. Templating has also been a powerful strategy in the synthesis of complex, covalently linked architectures.3,4 In coordination chemistry, metal ions have long been exploited to direct the formation of macrocyclic scaffolds,5,6 ranging from phthalocyanines as initial examples7 to more complex polycyclic compounds that serve as selective hosts for metal ions.8,9 Likewise, in supramolecular chemistry, templating has enabled the synthesis of a diverse array of challenging synthetic targets, including interlocked structures such as rotaxanes, catenanes, and molecular knots.1013 The scope of such synthetic efforts in chemical templating has been expanded through the use of biological building blocks such as DNA,14 the development of self-replicating peptides,1517 covalent capture strategies,1820 and, broadly, the advent of dynamic combinatorial/covalent chemistry.2123 These advances in synthetic templating strategies prompted us to explore whether they can also be employed toward the construction of discrete multiprotein assemblies, which execute most of the fundamental cellular tasks and, thus, are primarily responsible for biological complexity. Specifically, we asked if self-complementary, noncovalent interactions built onto a certain facet of a protein building block could yield a stable, supramolecular architecture by directing the selective formation of multiple disulfide bonds on other facets.

Quaternary protein structures and supramolecular protein architectures are assembled primarily through extensive non-covalent interactions, which form multiple interfaces between the constituent building blocks. The bottom-up construction of protein assemblies solely through the design and engineering of such noncovalent interfaces is a significant challenge, as, by necessity, each of these interfaces has to be extensive. Nevertheless, efforts in this area have started to yield impressive architectures, such as 2D layers24 and cagelike architectures,2527 particularly by exploiting supramolecular symmetry as a primary design element,28 which leads to cooperativity between the interfaces.

In this regard, disulfide bonds are particularly attractive as structure building tools, as they are considerably stronger (bond dissociation energy ≈ 60 kcal/mol)29 than noncovalent interactions and thus would not require the design or engineering of extensive molecular surfaces. Indeed, disulfide bond engineering is a well-established strategy to stabilize existing (i.e., already evolved) protein folds30,31 or protein–protein interfaces3235 and to covalently link protein building blocks for spatial preorganization27 or symmetrization36 with minimal structural perturbation. In addition, disulfide bonds are reversible through two-electron reduction and responsive to external stimuli, such as pH and ionic strength.37 This unique combination of stability, reversibility, and stimuli-responsiveness accounts for not only the prevalence of disulfide bonds in biological systems but also their increasing use in synthetic supramolecular chemistry.2123 Despite these advantages and some notable successes in peptide self-assembly,38 disulfide bonds are not commonly—if at all—exploited in multiples for the bottom-up assembly of discrete/closed supramolecular protein architectures. There are several reasons. First, this goal would necessitate the formation of several disulfide bonds in a selective fashion during protein self-assembly. This, in turn, would require the programming of a structural bias for positioning (i.e., templating) the correct cysteine pairs across from one another, a grand challenge on its own.39 Second, this goal would necessitate the consideration of the multiple assembly pathways involving alternative cysteine pairs, which may form deep kinetic traps.40 Third, protein constructs with multiple thiol groups are difficult to produce and handle in experimental settings.41 To our knowledge, there are no designed protein architectures that self-assemble via the formation of multiple disulfide bonds across different interfaces.

Recently, we have applied design strategies of supramolecular coordination chemistry to control the assembly of monomeric proteins into closed or infinite protein superstructures.4244 Our approach is based on the premise that the strength and directionality of metal coordination interactions built onto protein surfaces can direct the assembly of symmetrical protein superstructures, whose interfaces can be subsequently stabilized through the introduction of favorable noncovalent interactions around the metal nuclei. Here, we show that such engineered noncovalent interactions can template the selective formation of multiple disulfide bonds to yield a novel, macrocyclic superprotein architecture, whose assembly is uncoupled from metal coordination. This assembly, C81/C96RIDC14, features four interconnected disulfide bonds in a cryptand-like topology. By virtue of its topology and due to the fact that its self-assembly no longer depends on metal binding, C81/C96RIDC14 is highly preorganized for metal coordination, has a large internal cavity surrounding the metal sites, and is resistant to alterations in inner-sphere metal coordination, all of which constitute challenging targets for protein design. What is more, C81/C96RIDC14 correctly self-assembles and incorporates Zn(II) ions in bacterial cells, thus forging a link between synthetic supramolecular chemistry and synthetic biology.

RESULTS AND DISCUSSION

Design of C81/C96RIDC1

The protein construct C81/C96RIDC1 (the C81/C96 double mutant of Rosetta Interface Designed Cytochrome 1, Figure 1a), which is the monomeric building block for the C81/C96RIDC14 tetramer, is a derivative of the four-helix-bundle hemeprotein, cytochrome cb562.45 We previously reported a first-generation cytochrome cb562 mutant (MBPC1; Metal Binding Protomer of Cytochrome 1), which was engineered on its surface with metal coordinating residues (orange sticks in Figure 1a and b).46 Upon binding various divalent transition metal ions, MBPC1 was observed to assemble into discrete assemblies whose compositions and supramolecular symmetries were dictated by the stereochemical preferences of the metal ions.47 In particular, tetrahedral coordination of Zn(II) by residues His63, Asp74, His73, and His77 led to the formation of a tetrameric, D2 symmetric assembly (Figure 1b).46 Owing to its dihedral symmetry, Zn4:MBPC14 possesses an interlocked architecture with particularly extensive (~5000 Å2 total) but nonfavorable interfacial interactions, which are distributed over three pairs of orthogonal, C2-symmetric interfaces (i1, i2, and i3) (Figure 1b). These three interfaces are interconnected but nonoverlapping. Consequently, the stabilization of any of these interfaces should also favor the formation of the other two interfaces (as well as the entire assembly), yet, from a protein engineering perspective, they should be independently addressable for redesign.

Figure 1.

Figure 1

Structural features of cyt cb562 central to the design of C81/C96RIDC1. (a) Three stages of mutations made on cyt cb562 to convert it to C81/C96RIDC1. The mutated residues to construct MBPC1 and RIDC1 are shown as orange and cyan-colored sticks, respectively. Two engineered surface cysteines, C81 and C96, are highlighted in green and magenta, respectively. (b) D2 symmetric structure of Zn4:RIDC14 viewed down the C2″ axis, along which interface i3 is formed. i1 and i2 are formed along the orthogonal C2 and C2′ axes, which lie parallel to the plane of view. Hydrophobic residues inserted into i1, as well as the symmetrically related pairs of Glu81 and Thr96 residues in i2 and i3, which are mutated to Cys, are highlighted. (c, d) Close-up views of Glu81 and Thr96.

We had shown that i1, the most extensive and close-packed of the three interfaces, can be stabilized through the incorporation of six mostly hydrophobic mutations (cyan sticks in Figure 1a and b) onto the MBPC1 monomer surface to generate RIDC1 and subsequently its Zn-mediated tetramer Zn4:RIDC14, which is isostructural with Zn4:MBPC14.48 Indeed, in the absence of Zn(II) binding, RIDC1 was able to dimerize (Kd,dimer = 26 μM) via the engineered hydrophobic interactions in an antiparallel fashion, as was observed in the Zn-driven tetrameric architecture.48 i3 is too small for stabilization through noncovalent interactions, and though extensive, i2 features too wide a clearance between monomers for efficient hydrophobic packing. Nevertheless, both i2 and i3 present two pairs of symmetrically related residue positions (96–96′ in i2 and 81–81′ in i3) across from one another in close proximity for potentially forming Cys–Cys disulfide bonds (Cα–Cα distances <5.6 Å) (Figure 1c and d). Indeed, 96–96′ disulfide bonds were shown to be readily accommodated in the Zn4:RIDC14 tetramer.49 From a self-assembly viewpoint, it is important to note that, with only one surface Cys present, selectivity is not an issue, as the desired disulfide bond will always form. This is not the case when two Cys residues are present on the same protein building block, which may lead to the formation of a mixture of disulfide bonds and thereby to heterogeneous aggregates. Here, we set out to take advantage of the symmetry of the Zn-templated tetramer and probe whether complementary, noncovalent interactions built into the i1 interfaces can template the correct formation of four disulfide bonds (2 × Cys96-Cys96′ and 2 × Cys81-Cys81′) across the other two interfaces during self-assembly. We thus prepared the C81/C96RIDC1 mutant through Glu81Cys and Thr96Cys mutations (Figure 1a).

Oxidative Self-Assembly of C81/C96RIDC1

In the first set of experiments, solutions of isolated C81/C96RIDC1 (typically 50 μM in concentration) were subjected to air oxidation at room temperature, and the time-course for the formation of disulfide-containing products was determined by gel electrophoresis (SDS-PAGE) under denaturing and nonreducing conditions. The major products were a distinct tetrameric species (48 ± 2% in abundance) and various higher order aggregates (40 ± 3%) (Figure 2a, top panel). These products formed over the course of 24 h following a noticeable induction phase, during which a dimeric intermediate was transiently populated (Figure 2a, bottom panel). A small, but persistent population (5–8%) of trimeric species was also detected. At 35 °C, the rates of monomer consumption and tetramer/polymer production were considerably higher, and the induction period was largely eliminated, although the product distribution did not change significantly (Figure S1 of the Supporting Information (SI)). Inclusion of equimolar Zn(II) in the reaction mixture altered neither the rate of formation significantly nor the distribution of products (Figure S2 of the SI), suggesting that Zn(II) coordination does not contribute to the stability of the self-assembly intermediates.

Figure 2.

Figure 2

In vitro disulfide-mediated self-assembly of C81/C96RIDC1 at room temperature. (a) Time-course of the oxidative self-assembly of C81/C96RIDC1 (50 μM) at pH 7 as characterized by SDS-PAGE under nonreducing conditions. (b) Time-course of the disulfide-mediated self-assembly of C81/C96RIDC1 (50 μM) at pH 7 in the presence of 950 μM GSH and 50 μM GSSG. In parts a and b, the upper panels represent the images of the actual gels, and the bottom panels show the relative integrated intensities of the observed bands in the gels. The data are the mean of three measurements ± 1 SD. (c) Disulfide-mediated self-assembly of the three control variants, C81/C96MBPC1, A74/C81/C96RIDC1, and C25/C96RIDC1, in the presence or absence of Zn or GSH/GSSG redox buffer, as monitored by SDS-PAGE electrophoresis under nonreducing conditions.

These initial results can be explained in terms of the proposed self-assembly model shown in Figure 3. According to this model, the predominant pathway proceeds through the reversible dimerization of C81/C96RIDC1 (species 1) through the complementary interactions in i1 that yield a dimer (species 2). This proposed dimer has all four Cys residues correctly oriented for the formation of the closed tetramer (species 5), which is supported by the previously observed antiparallel arrangement of the metal-independent RIDC12 dimer.48 The remaining fraction of monomers can form disulfide-linked dimers (detectable as such in SDS-PAGE) that are either correctly paired (species 3) to form the closed tetramer through complementary i1 interactions or incorrectly paired (species 4), which would lead higher order aggregates (species 6) or a closed trimer (species 7).

Figure 3.

Figure 3

Proposed scheme for the disulfide-mediated self-assembly of C81/C96RIDC1. The dark- or light-gray-shaded circles correspond to the views of the four-helix protein building blocks from top or bottom as shown in Figure 1b. Dotted arrows indicate alternative pathways of oligomer formation. Residues C81 and C96 are illustrated as green and magenta sticks, and the hydrophobic residues in i1 as cyan patches, matching the coloring scheme in Figure 1.

Given that disulfide bond formation is largely irreversible under these experimental conditions, the templated formation of the closed C81/C96RIDC14 tetramer should be under kinetic control, whereby the noncovalent i1 interactions geometrically favor the formation of the four, correct disulfide bonds. Under the assumption that the closed tetramer–which has all of its interfaces correctly formed–is also the thermodynamically most favored product among those shown in Figure 3, we surmised that its formation should be favored under conditions that promote reversible disulfide bond formation (i.e., where all steps in Figure 3 operate under equilibrium). Toward this end, we utilized a redox buffer system containing reduced and oxidized forms of glutathione (GSH and GSSG, respectively). At a molar ratio of 19:1 GSH/GSSG (combined concentration of 1 mM, EpH7 = −187 mV),50 the yield for the tetramer after 1 day of oxidation indeed rose from 48% to 63 ± 9% (Figure 2b). As expected from a system under thermodynamic control, this increase in the yield compared to the non-redox-buffered system came primarily at the expense of the less stable, polymeric species, whose abundance decreased from 40% to 13 ± 6%. Under more oxidizing conditions (1:19 GSH/GSSG at 1 mM total concentration, EpH7 = −77 mV),50 the product distribution did not change significantly, although the reaction proceeded more rapidly, as expected (Figure S3 of the SI). Treatment with the strong reducing agent dithiothreitol (DTT, EpH7 = −330 mV)51 led to complete dissociation of all oligomeric products. Our results thus indicate that the disulfide bonds in C81/C96RIDC14 have reduction potentials (−200 to −300 mV) typical of natural systems and that even small amounts of GSH are sufficient to catalyze reversible disulfide exchange and ensure thermodynamic control.

To further probe the validity of our model, we prepared three control variants and examined their self-assembly under oxidative conditions. The first variant, C81/C96MBPC1, had the same two Cys residues but lacked the hydrophobic surface residues that stabilize and preorient the i1 interface. In contrast to C81/C96RIDC1, C81/C96MBPC1 did not display any preference for tetramer formation: after ~16 h of air oxidation, the main products were higher-order aggregates (~80% in abundance) with only ~7% in tetrameric form (Figure 2c, left panel). In this case, however, the addition of equimolar Zn(II) did yield a noticeable increase in the tetramer population (~20%), suggesting that Zn(II) coordination may help template the formation of the closed tetramer in the absence of the directing i1 interactions.

To conclusively establish that the templated formation of the C81/C96RIDC14 tetramer is independent of Zn(II) coordination, we prepared a second control variant, A74/C81/C96RIDC1, which featured an alanine substituted for one of the Zn-coordinating residues, Asp74. The elimination of the Zn-Asp74 linkage was chosen because this bond is critical in the stabilization of the i3 interface in the parent tetramer Zn4:MBPC14. The yield of tetramer formation for A74/C81/C96RIDC1 was not only unaffected in the presence or absence of Zn(II), but it was consistently higher than that of C81/C96RIDC1 under all conditions (Figure 2c, middle panel). In the presence of 1 mM GSH/GSSG buffer, the tetramer abundance reached 77 ± 3% after 16 h, with the remaining fraction mostly in the monomeric form. Based on these results, we can conclude that the D74A mutation must stabilize the closed tetramer (species 5), although the exact molecular details of this effect are not immediately apparent.

Our third control variant was an alternative double-Cys mutant C25/C96RIDC1, which could form the complementary i1 interactions but had a Cys installed in position 25, which is not compatible for self-pairing in the closed tetramer (Figure 1b). In the absence of any structural bias, two Cys residues on a given protein monomer should give rise to multiple modes of disulfide-cross-linking and, in turn, the formation of open oligo-and -polymers, with no particular enrichment of any intermediate n-mer. This was indeed our observation with C25/C96RIDC1 under all conditions tested (±Zn(II), ±GSH/GGSG), which formed a “ladder” of species with no distinct population of an intermediate (Figure 2c, right panel). Taken together, our observations clearly show that the hydrophobic interactions engineered into i1 are necessary and sufficient for directing the formation of the four desired disulfide bonds.

Structural and Chemical Characterization of C81/C96RIDC14 and Its Variants

The C81/C96RIDC14 tetramer was purified in high yield by size-exclusion chromatography for further characterization (Figure S4 of the SI). Sedimentation velocity experiments with C81/C96RIDC14 revealed a single, narrow peak with a maximum at 4.5 S, which slightly moved (to 4.6 S) upon addition of 4 equiv of ZnII, indicating the formation of a discrete, closed tetramer that does not undergo a large conformational change upon metal binding (Figure 4a). This was confirmed through the crystal structures of apo- and Zn-bound C81/C96RIDC14, which we determined at 2.1 and 1.2 Å resolution, respectively (Figure 4c and d; Table S1 and movies of the SI). An inspection of the core architectures of both structures (Figure 4e) reveals their striking topological resemblance to cryptands,52 in particular spheroidal cryptands,53 which are highly preorganized, covalently linked macropolycylic compounds designed to stably capture cations and anions in their cavities. The tetramers feature a macrocyclic base structure that is formed by the linkage of Helices 4 from each monomer by the two pairs of C96–C96′ and C81–C81′ disulfide bonds. This covalently linked macrocycle is capped from the top and the bottom by Helices 3 from each monomer, which are linked through the hydrophobic i1 interactions and help form a central cavity lined by the four Zn coordination sites (Figure 4f). Like cryptands, this large cavity (740 Å3 in apo-C81/C96RIDC14, 1220 Å3 in Zn4:C81/C96RIDC14, Figure S5 of the SI) and the Zn coordination sites are relatively well isolated from the bulk, owing to the packing of side chains in i1 and i2 interfaces (movies of the SI), particularly in the case of the apo structure. Again, in analogy to cryptands, C81/C96RIDC14 is highly preorganized for Zn(II) coordination. Structures of apo-C81/C96RIDC14 and Zn4:C81/C96RIDC14 display a small deviation from each other, with a root-mean-square deviation (rmsd) of 2.2 Å measured over the backbone α-carbons of the cryptand-like core (Figure 4e). The small rearrangement of the metal allows Trp41 and Trp66 side chains to extend fully into the interface and preserve their original hydrophobic contacts. The Zn(II) affinity of C81/C96RIDC14 was determined by a competition titration using the fluorescent metal indicator Fura-2 (Figure S6 of the SI), whose Zn(II) complex has a dissociation constant (Kd,Zn-Fura) of 5.7 nM.49 These titrations revealed that C81/C96RIDC14 bound four Zn(II) ions as expected, and the isotherm was well fit by a 2 + 2 Zn equilibrium model (i.e., two pairs of independent sites), with Kd1,2Zn= 2.6 ± 0.3 nM and Kd2,2Zn= 25 ± 4 nM (Figure 4b). ICP-OES experiments were carried out in parallel to examine the ability of C81/C96RIDC14 to bind various divalent metal ions. These experiments showed that C81/C96RIDC14 could indeed accommodate 4 ZnII equivalents as well as ≤1 CoII, 2 NiII, and >4 CuII ions (Figure S7 of the SI).

Figure 4.

Figure 4

Structural and physicochemical characterization of apo- and Zn-bound C81/C96RIDC14. (a) Sedimentation velocity profile of C81/C96RIDC14 (5 μM) in the presence and absence of equimolar Zn(II). (b) Zn-binding isotherm of C81/C96RIDC14 (2.75 μM) determined using Fura-2 (4.2 μM) as a competing ligand. Nearly equally good fits are obtained using a four consecutive Zn binding equilibrium model (1 + 1 + 1 + 1, dashed line) or a two consecutive binding equilibrium model (2 + 2, solid line), whereas a single binding equilibrium model (4 × 1, dotted line) does not appear to be adequate. (c, d) Crystal structures of apo- and Zn-bound C81/C96RIDC14. The C81–81 and C96–C96 disulfide bonds are shown as green/yellow and magenta/yellow sticks, respectively (for close-up views of the disulfide bonds and corresponding omit electron density maps, see Figure S13 of the SI). The hydrophobic residues in the i1 interface are highlighted in cyan. Interfacial disulfide bonds, except one C81–C81 bond in the background, are indicated with blue arrows. (e) Backbone superposition of the cryptand-like cores of apo- (cyan) and Zn-bound (dark gray) C81/C96RIDC14 and their comparison to a synthetic spheroidal cryptand (ref 53). The cryptand-like core is composed of residues 60–96 of each of the four protein monomers. The helical segments 81–96 form the outer, covalently linked periphery, whereas the helical segments 60–81 form part of the hydrophobic i1 interface that cap the core cavity from top and bottom (see movies of the SI). (f) The central cavity in Zn4:C81/C96RIDC14 lined by the four Zn coordination sites is highlighted in magenta.

The fact that the self-assembly of our cryptand-like scaffold was entirely uncoupled from Zn(II) coordination suggested that it could be utilized to construct unsaturated metal coordination sites. To examine this possibility, we crystallized the Zn complex of the aforementioned A74/C81/C96RIDC1 variant, which has the Zn-coordinating Asp74 carboxylate eliminated and can be isolated in its tetrameric form in high yield. The 2.3-Å structure of the tetramer shows that the four Zn ions are indeed coordinated only by the three original His side chains (His63, H73, and His77) and the fourth coordination site is occupied by a water molecule, closely mimicking the Zn coordination environment of carbonic anhydrases54 and matrix metalloproteinases55 (Figure 5). The covalently cross-linked cryptand-like topology is key to the construction of coordinatively unsaturated Zn sites, as the D74A mutant of RIDC1 (lacking C81/C96) was previously shown to form an asymmetric trimer upon Zn coordination, whereby the interfacial Zn ions were coordinatively saturated.56 Preliminary experiments with Zn4:A74/C81/C96RIDC14 using p-nitrophenyl acetate (PNPA) as a substrate for potential esterase activity suggested that the buried Zn sites were not accessible to this substrate; studies are currently ongoing to “carve out” access channels to the cryptand interior.

Figure 5.

Figure 5

Structural and Zn-binding properties of A74/C81/C96RIDC14. (a) Close-up view of one of the four identical 3His-Zn coordination sites, along with the corresponding 2FoFc electron density map contoured at 1.4σ (cyan) and 7σ (magenta). The Zn-coordinated water molecule is shown as a blue sphere. For close-up views of the disulfide bonds and corresponding omit electron density maps, see Figure S13 of the SI. (b) View of Zn4:A74/C81/C96RIDC14 down the C2″ axis and the i3 interface. The Cβ–Cβ distance (10.4 Å) between position 74 residues across the i3 interface is highlighted with a dashed line. The corresponding distance in Zn4:C81/C96RIDC14 is 8.8 Å. (c) Zn-binding isotherm of A74/C81/C96RIDC14 (13.5 μM) determined using Mag-Fura-2 (8.7 μM) as a competing ligand. Nearly equally good fits are obtained using a four consecutive Zn binding equilibrium model (1 + 1 + 1 + 1, dashed line), a two consecutive binding equilibrium model (2 + 2, solid line), and a single binding equilibrium model (4 × 1, dotted line).

Competition titrations using Mag-Fura-2 (Kd,Zn-MagFura2 = 47 nM)57 (Figure 5c and Figure S8 of the SI) could be adequately described by a 4 × 1 Zn equilibrium model (i.e., four independent, equivalent binding sites), yielding Kd,4Zn = 480 ±35 nM for A74/C81/C96RIDC14. This dissociation constant is approximately 1 to 2 orders of magnitude higher than those determined for C81/C96RIDC14, consistent with the loss of a coordinating ligand. The elimination of the D74-Zn coordination leads to a slight widening of the i3 and subsequently the i1 interfaces (Figure 5b), all of which are reflected in an increased cavity volume of 2100 Å3 (Figure S5 of the SI). Despite this potentially drastic perturbation to the inner Zn-coordination sphere, the cryptand-core of Zn4:A74/C81/C96RIDC14 is superposable onto that of Zn4:C81/C96RIDC14 with an rmsd of 1.6 Å (Figure S9 of the SI), further highlighting the structural rigidity afforded by the covalently interconnected topology.

Cellular Self-Assembly of C81/C96RIDC14

The gene encoding for C81/C96RIDC1 is equipped with an engineered N-terminal signal sequence, which enables the translocation of the protein upon translation into the E. coli periplasm, where it is processed for the covalent (c-type) linking of the heme cofactor to the protein backbone.45,58 The periplasmic space is an oxidizing environment and contains the biological machinery for disulfide bond formation and exchange.40 This raised the possibility that C81/C96RIDC1 might correctly self-assemble into the cryptand-like tetramer in bacterial cells and, given its relatively high Zn-affinity, compete for Zn ions. To test this possibility, we performed a periplasmic extraction of the C81/C96RIDC1-overexpressing E. coli cells through osmotic shock, which lyses the outer but not the inner membrane, such that any disulfide-linked products remain isolated from the cytosolic reductants. Solutions used for lysis or any other step thereafter also contained 50 mM iodoacetic acid for alkylating any free cysteines and disabling any postlysis disulfide bond formation. Crude periplasmic lysates of C81/C96RIDC1-over-expressing cells were immediately analyzed by nonreducing, SDS-PAGE, using 3,3′,5,5′-tetramethylbenzidine (TMBZ) as the staining agent to detect heme-containing proteins59 (Figure 6a) or Coomassie Blue to image the entire protein content (Figure S10 of the SI). The TMBZ-stained gels indicated a prominent band (~63% abundance among all stained species, Figure 6a, left panel) near the 46-kDa molecular weight marker that would correspond to the C81/C96RIDC14 tetramer (expected mass = 49,108 Da). When SDS-PAGE was carried out after the treatment of the extracts with DTT to reduce disulfide bonds, the main band moved to where a monomeric species would be expected (Figure 6a, right panel), establishing that C81/C96RIDC1 primarily exists as a disulfide-linked tetramer in the periplasm. A similar SDS-PAGE profile was obtained in the case of the cells that overexpressed A74/C81/C96RIDC1 (Figure 6a), with a tetramer abundance of ~60%. In contrast, periplasmic extracts of MBPC1 and RIDC1, which do not self-assemble into tetramers in vitro, consisted almost entirely of monomers. Extracts of C81/C96MBPC1 contained a distribution of n-mers with no appreciable population of a tetrameric species (Figure 6a), paralleling the findings of the self-assembly experiments carried out in vitro (Figure 1c) and reaffirming the necessity/sufficiency of hydrophobic i1 interactions in templating the formation of C81/C96RIDC14. It remains to be determined whether disulfide-exchange enzymes such as DsbA (E′ ≈ −100 mV)60 are directly involved in the self-assembly of C81/C96RIDC14 in the periplasm.

Figure 6.

Figure 6

Disulfide-mediated self-assembly and Zn binding properties of C81/C96RIDC1 in E. coli cells. (a) SDS-PAGE analysis of the periplasmic extracts of MBPC1 (lane 2), C81/C96MBPC1 (lane 3), RIDC1 (lane 4), C81/C96RIDC1 (lane 5), and A74/C81/C96RIDC1 (lane 6). Electrophoresis was carried out under nonreducing conditions using untreated extracts (left panel) or DTT-treated extracts (right panel). The gels were stained with TMBZ for heme detection. For the corresponding Coomassie-stained gels, see Figure S9 of the SI. (b) ICP-OES analysis of the Zn content of self-assembled C81/C96RIDC14 tetramers isolated from the periplasmic extracts of E. coli cells grown in LB media under various conditions.

The red-colored periplasmic extract displayed a UV–vis spectrum that was typical of reduced cyt cb562, with Q-band maxima at 525 and 556 nm,45 respectively (Figure S11 of the SI). The species corresponding to C81/C96RIDC14 was isolated by size exclusion chromatography. The MALDI mass spectrum displayed a single peak at 49,133 Da in the MALDI mass spectrum (Figure S12 of the SI), slightly (25 amu) above the expected mass of the C81/C96RIDC14 tetramer. These results establish that C81/C96RIDC14 correctly self-assembles in E. coli cells; we estimate the periplasmic concentration of C81/C96RIDC14 to be 10–20 μM (SI).

We next tested the ability of C81/C96RIDC14 to compete for Zn(II) ions in bacterial cells. In terms of metal homeostasis, the periplasmic space of Gram-negative bacteria serves as a buffer zone that screens the cytoplasm from large environmental fluctuations in metal ion concentrations as part of the so-called envelope stress response.61 Though not to the extent seen in the cytoplasm, competition for Zn(II) in the periplasm is still keen. The periplasmic free Zn(II) concentration is tightly regulated by transport systems such as ZnuABC (Kd, Zn-ZnuA <20 nM)62 and ZIP proteins,63 and the periplasm contains many essential Zn-containing proteins (~20 known), including β-lactamase and superoxide dismutase.64 In a typical experiment, C81/C96RIDC1-expressing E. coli cells were grown in Luria–Bertani (LB) broth, the periplasmic C81/C96RIDC14 tetramers were isolated using strictly metal-free buffer solutions and glassware, and their zinc and iron contents were determined via ICP-OES. Here, the iron content served as a convenient indicator of protein concentration, as each C81/C96RIDC1 monomer contains one iron atom in the covalently bound heme cofactor. When the cells were grown in unsupplemented LB medium ([Zn]LB≈10 μM),65,66 the isolated C81/C96RIDC14 tetramers contained no detectable amount of zinc (Figure 6b). The detection limit in these experiments was <0.1 ppm metal (lowest data point in our calibration line), which corresponded to <0.15 equiv of metal ion per tetramer. However, when the medium was supplemented with 50 or 100 μM ZnCl2, the tetramers accumulated 0.52 ± 0.16 or 1.4 ± 0.6 Zn equiv, respectively (Figure 6b). No detectable amounts of other relevant divalent metal ions (CoII, NiII, CuII) were found to be associated with the tetramer, and the possibility of extrinsic (nonheme) FeII binding was ruled out, as the concentration of FeII associated with the sample matched the monomeric protein concentration determined by using the extinction coefficient of the heme Soret band. Under the same experimental conditions, periplasmic extracts of non-self-assembling variants MBPC1 and RIDC1 did not contain any detectable Zn, indicating that Zn sequestration in the cell necessitates the formation of the cryptand-like tetramer. Competition by natural Zn-proteins and active regulation of the periplasmic Zn concentration likely prevent the entire population of C81/C96RIDC14 tetramers from attaining stoichiometric Zn(II) binding. A more definitive picture would require knowledge of the concentrations and Zn-affinities of each Zn-binding protein in the periplasm alongside C81/C96RIDC14. Nevertheless, our results indicate that C81/C96RIDC14 is able to successfully vie for Zn(II) in cells and sequester it from the environment.

CONCLUSIONS

Despite their ubiquity in natural protein assemblies and the structural and functional advantages they confer, disulfide bonds are rarely utilized in multiples for the design and self-assembly of discrete protein architectures. Here, we have described a protein design strategy inspired by supramolecular chemistry, in which noncovalently interacting protein surfaces template the selective formation of multiple disulfide bonds across different interfaces to yield a novel, cryptand-like protein assembly in a one-pot reaction. The design of C81/C96RIDC1 was based on the D2 symmetry of the Zn-templated parent architecture (Zn4:MBPC14), which presented three sets of interconnected interfaces with C2 symmetry that guided the correct placement of Cys residues. It is important to note that D2-symmetric tetramers are significantly overrepresented among all known tetrameric protein structures, in which the connectivity of the interfaces leads to more compact/stable structures and allows facile incorporation of function or allostery.67,68

The structure and design of C81/C96RIDC14 is noteworthy from several viewpoints. Owing to its cryptand-like topology and connectivity, C81/C96RIDC14 is highly preorganized for metal binding in its interior and possesses a large, protected cavity in its center. Both of these structural features are prominent characteristics of natural metalloenzyme architectures but challenging goals for de novo protein design.69,70 In fact, the most successful metalloprotein/enzyme design approaches largely bypass the protein folding problem by utilizing either existing protein folds7173 or canonical folding motifs (e.g., α-helical coiled coils)74,75 whose interiors are engineered/repurposed for constructing metal binding sites. Second, C81/C96RIDC14 illustrates an important advantage of using noncovalently (or “remotely”) templated disulfide bonds for engineering tailorable protein architectures. Namely, the three pairs of interfaces that make up C81/C96RIDC14 (i1, i2, and i3) bury a total surface area of nearly ~5000 Å2 excluding the interior cavity, yet the total surface area of designed noncovalent interactions in i1 (which are sufficient for directing disulfide bond formation across i2 and i3) cover only 2000 Å2. This suggests that a significant portion of the i2 and i3 interfaces, which are solely connected through disulfide bonds, may be subjected to alterations–for example, to carve out access channels to the interior cavity–without disrupting the overall structure of the assembly. Hypothetically, engineering a stable architecture similar to C81/C96RIDC14 purely through noncovalent interactions would not only require the design of all three interfaces (i.e., covering close to 5000 Å2), but the resulting architecture would also be far more sensitive to alterations in its interfaces. Third, C81/C96RIDC1 (a protein that self-assembles into a metalloenzyme-like supramolecular architecture) is separated from its progenitor cyt cb562 (a putative electron transfer protein) by only 11 surface point mutations; that is, they share ~90% sequence identity. This feature recapitulates, in a synthetic system, how nature can take advantage of a limited number of protein domains and folding motifs to create entirely new structures and functions.76 Finally, C81/C96RIDC14 is a synthetic supramolecular complex, yet it consists of entirely natural components and is able to correctly self-assemble in bacterial cells and incorporate the desired metal ion in a highly competitive environment. This raises the tantalizing prospect of constructing novel supramolecular or bioinorganic scaffolds in living systems that can be subjected to selective pressure for the evolution of new and improved biological functions.

MATERIALS AND METHODS

Disulfide-Mediated C81/C96RIDC1 Self-Assembly

Upon purification (see SI), C81/C96RIDC1 was concentrated to 2–4 mM in an Amicon stirred cell using a 10-kDa cutoff membrane. To the C81/C96RIDC1 stock solution was added an excess (100 mM) of dithiothreitol (DTT) to dissociate any disulfide bonds. After a 30-min incubation, the protein solution was eluted through a 10DG desalting column (BioRad) to remove DTT, using a running buffer solution of 50 mM TRIS (pH 7) and 150 mM NaCl. The protein concentration was adjusted to 50 μM using the same buffer solution. Immediately, several 20-μL aliquots of the protein solution were transferred to 0.65-mL centrifuge tubes, and to these aliquots were added either 1 mol equiv of ZnCl2, 1 mM 1:19 GSH/GSSG, 1 mM 19:1 GSH/GSSG, or nothing. Samples were incubated under air exposure, either at room temperature or in an Eppendorf thermocycler at 35 °C. Aliquots (1-μL) from each sample were taken at desired time intervals over a period of 24 h; any remaining free cysteines in these solutions were passivated by addition of 50 mM iodoacetic acid and nonreducing SDS-PAGE loading buffer (bromophenol blue, 10% SDS, glycerol, 1.5 M Tris, pH 6.8). The aliquots were applied to 12% SDS-PAGE gels and run for 40 min at 400 V in a BioRad MiniProtean TetraCell box. Gels were stained with Coomassie Blue for 10 min and then destained for 1–2 h in a 10% nitric acid/30% methanol solution. They were then imaged using a scanner, and protein band intensities were integrated using ImageJ.77

Preparation and Isolation of Tetrameric C81/C96RIDC14 and A74/C81/C96RIDC14

As described above, purified and concentrated C81/C96RIDC1 (2–4 mM) was first treated with DTT to reduce any preformed disulfide bonds. After removal of DTT, to the protein stock solution was added 1 mM of 1:19 GSH/GSSG and the solution was incubated at 35 °C for 16–20 h to form the C81/C96RIDC14 tetramer in high yield. The tetramer was isolated from other oligomeric species by fast protein liquid chromatography on a DuoFlow workstation (Bio-Rad), using a XK26/100 column (GE Healthcare) packed with Superdex 75 (GE Healthcare) and a running buffer solution of 20 mM TRIS (pH 7) and 150 mM NaCl (Figure S4 of the SI). The tetramer fraction was identified by SDS-PAGE under nonreducing conditions. The tetramer was concentrated, and excess EDTA (>10 mM) was added to remove any metal ions bound to the protein during purification. The protein stock solution was exchanged into a Chelex-treated buffer solution of 20 mM MOPS (pH 7) and 150 mM NaCl, flash-frozen in 200-μL aliquots and kept at −80 °C until further use.

Periplasmic Protein Extraction and Heme Staining

A 1-L cell culture expressing the protein variant of interest was harvested after 16 h of growth by centrifugation, and the cell pellet (~7 g) was washed three times with a resuspension buffer (10 mM TRIS, pH 7.4, 33 mM NaCl). Cold osmotic shock was performed by first suspending the cell pellet in 10 volumes of the resuspension buffer (70 mL), followed by the addition of 10 volumes of 40% sucrose (70 mL) and excess iodoacetic acid (>50 mM). After incubation in an ice bath for 10 min, the cell suspension was centrifuged at 6000 rpm, and the cell pellet was resuspended with 20 volumes (140 mL) of ice-cold solution of 10 mM TRIS (pH 7.4), 0.5 mM MgCl2, and 50 mM iodoacetic acid. After another 10-min incubation, the cell suspension was once again centrifuged (20 min, 8000 rpm), whereby the supernatant contained the red-colored periplasmic extract. The supernatant was concentrated using an Amicon stirred cell, and 15 μL of the concentrated sample was run on a nonreducing, 12% SDS-PAGE gel for 40 min at 400 mV. The gel was immersed in a solution of 30 mL of 6.3 mM tetramethylbenzidine (TMBZ) and 70 mL of 0.25 M sodium acetate (pH 5) in the dark for 1–2 h, after which 30 mM hydrogen peroxide was added to the solution. The gel was incubated for another 30 min to allow full development of heme-containing bands, which were imaged on a scanner and integrated using ImageJ.77

Competitive Zn(II) Binding Titrations

A 1-mL solution containing 4 μM Fura-2 (Life Technologies) and 2–3 μM C81/C96RIDC4 was titrated in a 1-cm cuvette with 1–2 μL aliquots of 1 mM ZnCl2. After each addition, the sample was equilibrated for at least 5 min at room temperature, upon which the excitation scan was recorded on a Horiba Fluorolog 2 fluorimeter using an excitation range of 250–450 nm and detection at 510 nm. The change in excitation intensity at 335 nm was plotted versus Zn(II) concentration, and the resulting curve was fit alternatively to 1 × 4 Zn, 2 × 2 Zn, or 4 × 1 Zn binding models using Dynafit78 as described previously.49 A similar protocol was used in the case of A74/C81/C96RIDC14 (13.5 μM) in competition titration experiments with Mag-Fura-2 (Life Technologies) (8.7 μM, excitation range of 300–400 nm, emission detection at 505 nm). The change in excitation intensity at 370 nm was plotted versus Zn(II) concentration, and the resulting curve was fit alternatively to 1 × 4 Zn, 2 × 2 Zn, or 4 × 1 Zn binding models by Dynafit.

Supplementary Material

Supplementary Files

Acknowledgments

We thank Dr. Woon Ju Song for helpful discussions and experimental guidance. Portions of this research were carried out at SSRL, operated by Stanford University on behalf of DOE. This work was supported by NSF (CHE-0908115), the Beckman Foundation, and the Sloan Foundation. F.A.T. was additionally supported by DOE-BES, Division of Materials Sciences and Engineering under the award DE-FG02-10ER46677 (protein crystallography), A.M.-M. by a traineeship under the NIH Cell and Molecular Genetics Training Grant, and A.P. by the UCSD MARC (NIH) and Amgen Scholars programs.

Footnotes

Notes

The authors declare no competing financial interest.

Supporting Information

Supporting Methods, Supporting Figures S1–S13, Supporting Movies S1 and S2 and Supporting Table S1 are available. This material is available free of charge via the Internet at http://pubs.acs.org.

References

  • 1.Busch DH. J Inclusion Phenom. 1992;12:389. [Google Scholar]
  • 2.Anderson S, Anderson HL, Sanders JKM. Acc Chem Res. 1993;26:469. [Google Scholar]
  • 3.McMurry TJ, Raymond KN, Smith PH. Science. 1989;244:938. doi: 10.1126/science.2658057. [DOI] [PubMed] [Google Scholar]
  • 4.Furlan RLE, Otto S, Sanders JKM. Proc Natl Acad Sci USA. 2002;99:4801. doi: 10.1073/pnas.022643699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Thompson MC, Busch DH. J Am Chem Soc. 1964;86:3651. [Google Scholar]
  • 6.Day VW, Marks TJ, Wachter WA. J Am Chem Soc. 1975;97:4519. [Google Scholar]
  • 7.Byrne GT, Linstead RP, Lowe AR. J Chem Soc. 1934:1017. [Google Scholar]
  • 8.McMurry TJ, Rodgers SJ, Raymond KN. J Am Chem Soc. 1987;109:3451. [Google Scholar]
  • 9.Creaser II, Geue RJ, Harrowfield JM, Herlt AJ, Sargeson AM, Snow MR, Springborg J. J Am Chem Soc. 1982;104:6016. [Google Scholar]
  • 10.Sauvage JP. Acc Chem Res. 1990;23:319. [Google Scholar]
  • 11.Cantrill SJ, Chichak KS, Peters AJ, Stoddart JF. Acc Chem Res. 2004;38:1. doi: 10.1021/ar040226x. [DOI] [PubMed] [Google Scholar]
  • 12.Ponnuswamy N, Cougnon FBL, Clough JM, Pantos GD, Sanders JKM. Science. 2012;338:783. doi: 10.1126/science.1227032. [DOI] [PubMed] [Google Scholar]
  • 13.Beves JE, Blight BA, Campbell CJ, Leigh DA, McBurney RT. Angew Chem, Int Ed. 2011;50:9260. doi: 10.1002/anie.201007963. [DOI] [PubMed] [Google Scholar]
  • 14.Aldaye FA, Sleiman HF. J Am Chem Soc. 2007;129:10070. doi: 10.1021/ja073305n. [DOI] [PubMed] [Google Scholar]
  • 15.Lee DH, Granja JR, Martinez JA, Severin K, Ghadiri MR. Nature. 1996;382:525. doi: 10.1038/382525a0. [DOI] [PubMed] [Google Scholar]
  • 16.Yao S, Ghosh I, Zutshi R, Chmielewski J. J Am Chem Soc. 1997;119:10559. [Google Scholar]
  • 17.Carnall JMA, Waudby CA, Belenguer AM, Stuart MCA, Peyralans JrmJ-P, Otto S. Science. 2010;327:1502. doi: 10.1126/science.1182767. [DOI] [PubMed] [Google Scholar]
  • 18.Clark TD, Ghadiri MR. J Am Chem Soc. 1995;117:12364. [Google Scholar]
  • 19.Krishnan-Ghosh Y, Balasubramanian S. Angew Chem, Int Ed Engl. 2003;42:2171. doi: 10.1002/anie.200250551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Hartgerink JD, Beniash E, Stupp SI. Science. 2001;294:1684. doi: 10.1126/science.1063187. [DOI] [PubMed] [Google Scholar]
  • 21.Cougnon FBL, Sanders JKM. Acc Chem Res. 2011;45:2211. doi: 10.1021/ar200240m. [DOI] [PubMed] [Google Scholar]
  • 22.Corbett PT, Leclaire J, Vial L, West KR, Wietor JL, Sanders JKM, Otto S. Chem Rev. 2006;106:3652. doi: 10.1021/cr020452p. [DOI] [PubMed] [Google Scholar]
  • 23.Sadownik JW, Ulijn RV. Curr Opin Biotechnol. 2010;21:401. doi: 10.1016/j.copbio.2010.05.010. [DOI] [PubMed] [Google Scholar]
  • 24.Sinclair JC, Davies KM, Venien-Bryan C, Noble MEM. Nat Nanotechnol. 2011;6:558. doi: 10.1038/nnano.2011.122. [DOI] [PubMed] [Google Scholar]
  • 25.King NP, Sheffler W, Sawaya MR, Vollmar BS, Sumida JP, André I, Gonen T, Yeates TO, Baker D. Science. 2012;336:1171. doi: 10.1126/science.1219364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Lai YT, Cascio D, Yeates TO. Science. 2012;336:1129. doi: 10.1126/science.1219351. [DOI] [PubMed] [Google Scholar]
  • 27.Fletcher JM, Harniman RL, Barnes FRH, Boyle AL, Collins A, Mantell J, Sharp TH, Antognozzi M, Booth PJ, Linden N, Miles MJ, Sessions RB, Verkade P, Woolfson DN. Science. 2013;340:595. doi: 10.1126/science.1233936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Padilla JE, Colovos C, Yeates TO. Proc Natl Acad Sci USA. 2001;98:2217. doi: 10.1073/pnas.041614998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Singh R, Whitesides GM. Sulphur-Containing Functional Groups. John Wiley & Sons, Inc; 1993. p. 633. [Google Scholar]
  • 30.Perry LJ, Wetzel R. Science. 1984;226:555. doi: 10.1126/science.6387910. [DOI] [PubMed] [Google Scholar]
  • 31.Wells JA, Powers DB. J Biol Chem. 1986;261:6564. [PubMed] [Google Scholar]
  • 32.Sauer RT, Hehir K, Stearman RS, Weiss MA, Jeitlernilsson A, Suchanek EG, Pabo CO. Biochemistry. 1986;25:5992. doi: 10.1021/bi00368a024. [DOI] [PubMed] [Google Scholar]
  • 33.Gokhale RS, Agarwalla S, Francis VS, Santi DV, Balaram P. J Mol Biol. 1994;235:89. doi: 10.1016/s0022-2836(05)80018-x. [DOI] [PubMed] [Google Scholar]
  • 34.Scrutton NS, Berry A, Perham RN. FEBS Lett. 1988;241:46. doi: 10.1016/0014-5793(88)81028-7. [DOI] [PubMed] [Google Scholar]
  • 35.Shirakawa M, Matsuo H, Kyogoku Y. Protein Eng. 1991;4:545. doi: 10.1093/protein/4.5.545. [DOI] [PubMed] [Google Scholar]
  • 36.Banatao DR, Cascio D, Crowley CS, Fleissner MR, Tienson HL, Yeates TO. Proc Natl Acad Sci U S A. 2006;103:16230. doi: 10.1073/pnas.0607674103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Singh R, Whitesides GM. Sulphur-Containing Functional Groups. John Wiley & Sons, Inc; 1993. p. 633. (published online 2010) [Google Scholar]
  • 38.Royo M, Contreras MÄ, Giralt E, Albericio F, Pons M. J Am Chem Soc. 1998;120:6639. [Google Scholar]
  • 39.Wu C, Leroux JC, Gauthier MA. Nat Chem. 2012;4:1044. doi: 10.1038/nchem.1487. [DOI] [PubMed] [Google Scholar]
  • 40.Mamathambika BS, Bardwell JC. Ann Rev Cell Dev Biol. 2008;24:211. doi: 10.1146/annurev.cellbio.24.110707.175333. [DOI] [PubMed] [Google Scholar]
  • 41.Craik DJ. Nat Chem. 2012;4:600. doi: 10.1038/nchem.1417. [DOI] [PubMed] [Google Scholar]
  • 42.Salgado EN, Radford RJ, Tezcan FA. Acc Chem Res. 2010;43:661. doi: 10.1021/ar900273t. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Radford RJ, Brodin JD, Salgado EN, Tezcan FA. Coord Chem Rev. 2011;255:790. [Google Scholar]
  • 44.Brodin JD, Ambroggio XI, Tang CY, Parent KN, Baker TS, Tezcan FA. Nat Chem. 2012;4:375. doi: 10.1038/nchem.1290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Faraone-Mennella J, Tezcan FA, Gray HB, Winkler JR. Biochemistry. 2006;45:10504. doi: 10.1021/bi060242x. [DOI] [PubMed] [Google Scholar]
  • 46.Salgado EN, Faraone-Mennella J, Tezcan FA. J Am Chem Soc. 2007;129:13374. doi: 10.1021/ja075261o. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Salgado EN, Lewis RA, Mossin S, Rheingold AL, Tezcan FA. Inorg Chem. 2009;48:2726. doi: 10.1021/ic9001237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Salgado EN, Ambroggio XI, Brodin JD, Lewis RA, Kuhlman B, Tezcan FA. Proc Natl Acad Sci USA. 2010;107:1827. doi: 10.1073/pnas.0906852107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Brodin JD, Medina-Morales A, Ni T, Salgado EN, Ambroggio XI, Tezcan FA. J Am Chem Soc. 2010;132:8610. doi: 10.1021/ja910844n. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Jones DP. In: Methods in Enzymology. Helmut S, Lester P, editors. Vol. 348. Academic Press; 2002. p. 93. [DOI] [PubMed] [Google Scholar]
  • 51.Cleland WW. Biochemistry. 1964;3:480. doi: 10.1021/bi00892a002. [DOI] [PubMed] [Google Scholar]
  • 52.Lehn JM. Acc Chem Res. 1978;11:49. [Google Scholar]
  • 53.Graf E, Lehn JM. J Am Chem Soc. 1975;97:5022. [Google Scholar]
  • 54.Christianson DW, Fierke CA. Acc Chem Res. 1996;29:331. [Google Scholar]
  • 55.Lovejoy B, Cleasby A, Hassell AM, Longley K, Luther MA, Weigl D, McGeehan G, McElroy AB, Drewry D, Lambert MH, Jordan SR. Science. 1994;263:375. doi: 10.1126/science.8278810. [DOI] [PubMed] [Google Scholar]
  • 56.Ni TW, Tezcan FA. Angew Chem, Int Ed. 2010;49:7014. doi: 10.1002/anie.201001487. [DOI] [PubMed] [Google Scholar]
  • 57.Salgado EN, Brodin JD, To MM, Tezcan FA. Inorg Chem. 2011;50:6323. doi: 10.1021/ic200746m. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Braun M, Thony-Meyer L. Proc Natl Acad Sci USA. 2004;101:12830. doi: 10.1073/pnas.0402435101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Thomas PE, Ryan D, Levin W. Anal Biochem. 1976;75:168. doi: 10.1016/0003-2697(76)90067-1. [DOI] [PubMed] [Google Scholar]
  • 60.Wunderlich M, Glockshuber R. Protein Sci. 1993;2:717. doi: 10.1002/pro.5560020503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Raivio TL. Mol Microbiol. 2005;56:1119. doi: 10.1111/j.1365-2958.2005.04625.x. [DOI] [PubMed] [Google Scholar]
  • 62.Yatsunyk LA, Easton JA, Kim LR, Sugarbaker SA, Bennett B, Breece RM, Vorontsov II, Tierney DL, Crowder MW, Rosenzweig AC. J Biol Inorg Chem. 2008;13:271. doi: 10.1007/s00775-007-0320-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Guerinot ML. Biochem Biophys Acta. 2000;1465:190. doi: 10.1016/s0005-2736(00)00138-3. [DOI] [PubMed] [Google Scholar]
  • 64.Hantke K. Curr Opin Microbiol. 2005;8:196. doi: 10.1016/j.mib.2005.02.001. [DOI] [PubMed] [Google Scholar]
  • 65.Outten CE, O’Halloran TV. Science. 2001;292:2488. doi: 10.1126/science.1060331. [DOI] [PubMed] [Google Scholar]
  • 66.Taylor PK, Parks BYA, Kurtz DM, Amster IJ. J Biol Inorg Chem. 2001;6:201. doi: 10.1007/s007750000197. [DOI] [PubMed] [Google Scholar]
  • 67.Goodsell DS, Olson AJ. Annu Rev Biophys Struct. 2000;29:105. doi: 10.1146/annurev.biophys.29.1.105. [DOI] [PubMed] [Google Scholar]
  • 68.Janin Jl. Science. 2008;319:165. doi: 10.1126/science.1152930. [DOI] [PubMed] [Google Scholar]
  • 69.Lu Y, Yeung N, Sieracki N, Marshall NM. Nature. 2009;460:855. doi: 10.1038/nature08304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Der BS, Edwards DR, Kuhlman B. Biochemistry. 2012;51:3933. doi: 10.1021/bi201881p. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Park HS, Nam SH, Lee JK, Yoon CN, Mannervik B, Benkovic SJ, Kim HS. Science. 2006;311:535. doi: 10.1126/science.1118953. [DOI] [PubMed] [Google Scholar]
  • 72.Khare SD, Kipnis Y, Greisen P, Jr, Takeuchi R, Ashani Y, Goldsmith M, Song Y, Gallaher JL, Silman I, Leader H, Sussman JL, Stoddard BL, Tawfik DS, Baker D. Nat Chem Biol. 2012;8:294. doi: 10.1038/nchembio.777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Koehler V, Wilson YM, Duerrenberger M, Ghislieri D, Churakova E, Quinto T, Knoerr L, Haussinger D, Hollmann F, Turner NJ, Ward TR. Nat Chem. 2013;5:93. doi: 10.1038/nchem.1498. [DOI] [PubMed] [Google Scholar]
  • 74.Reig AJ, Pires MM, Snyder RA, Wu Y, Jo H, Kulp DW, Butch SE, Calhoun JR, Szyperski TG, Solomon EI, DeGrado WF. Nat Chem. 2012;4:900. doi: 10.1038/nchem.1454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Zastrow ML, Peacock FA, Stuckey JA, Pecoraro VL. Nat Chem. 2012;4:118. doi: 10.1038/nchem.1201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Chothia C, Gough J, Vogel C, Teichmann SA. Science. 2003;300:1701. doi: 10.1126/science.1085371. [DOI] [PubMed] [Google Scholar]
  • 77.Schneider CA, Rasband WS, Eliceiri KW. Nat Methods. 2012;9:671. doi: 10.1038/nmeth.2089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Kuzmic P. Anal Biochem. 1996;237:260. doi: 10.1006/abio.1996.0238. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Files

RESOURCES